Achieve Life Sciences Inc. (NASDAQ: ACHV)
$4.94
+0.1100 ( +2.28% ) 124.4K
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Market Data
Open
$4.94
Previous close
$4.83
Volume
124.4K
Market cap
$169.99M
Day range
$4.86 - $5.01
52 week range
$3.03 - $5.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 27, 2024 |
8-k | 8K-related | 11 | Jun 06, 2024 |
8-k | 8K-related | 13 | May 09, 2024 |
10-q | Quarterly Reports | 60 | May 09, 2024 |
def | Proxies and info statements | 7 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |
4 | Insider transactions | 1 | Apr 23, 2024 |